Pharma-X

Open access

ISSN: 3117-9770

Pharma-X

Open access

Editor-in-Chief

Yuji Wang

Editorial Board

OverviewPharma-X is an international, peer-reviewed, open-access journal dedicated to the transformative intersection of Medicine, Pharmacy, and Engineering. The "X" in Pharma-X stands for Cross-disci...

Overview
Pharma-X is an international, peer-reviewed, open-access journal dedicated to the transformative intersection of Medicine, Pharmacy, and Engineering.

The "X" in Pharma-X stands for Cross-disciplinary synergy, eXploration of the unknown, and the infinite possibilities inherent in the integration of engineering precision with medical science.

Aims
Our mission is to foster a new era of healthcare innovation by bridging the gap between advanced engineering principles and pharmaceutical/clinical needs. Pharma-X aims to publish disruptive technologies and fundamental breakthroughs that accelerate the transition from "bench to bedside" through smart engineering.

Scope of Interest
Pharma-X welcomes original research, comprehensive reviews, and visionary perspectives. Our scope is organized into four primary innovative dimensions:

Section A: Pharmacy-Engineering Integration

This section focuses on engineering-driven solutions in pharmaceutical sciences, including:

  • Smart Drug Delivery: Nano-robotics, bio-responsive carriers, and intelligent controlled-release systems.

  • Pharmaceutical Manufacturing: 3D/4D bioprinting of drugs, automated synthesis, and "factory-on-a-chip."

  • Advanced Biomaterials:Engineering of smart materials for drug loading, targeting, and biocompatibility.

Section B: Medicine-Engineering Integration

This section highlights the application of engineering in clinical medicine, including:

  • Medical Robotics & AI: Surgical robots, AI-driven diagnostics, and intelligent rehabilitation systems.

  • Medical Devices & Sensors: Wearable health monitors, implantable bio-electronics, and advanced imaging technology.

  • Tissue Engineering:Engineering of scaffolds and organ-on-a-chip models for regenerative medicine and disease modeling.

Section C: Convergence Science & Digital Health

  • This section explores the "infinite possibilities" of emerging technologies:

  • Digital Medicine: Big data, machine learning in healthcare, and telemedicine infrastructures.

  • Bioinformatics & Systems Biology: Multi-omics data integration and computational modeling for precision medicine.

  • Neural Engineering: Brain-computer interfaces and neuro-prosthetics.

Section D: Translational Research & Innovation

  • This section is dedicated to the practical application and industrialization of medical technology:

  • Clinical Translation: Reports on the first-in-human application of innovative engineering devices.

  • Regulatory Science:Studies on the safety, ethics, and policy of medical-engineering innovations.

  • Disruptive Innovation: High-risk, high-reward concepts that challenge existing medical paradigms.

Editorial Board

Stay Informed

Register your interest and receive email alerts tailored to your needs. Sign up below.